CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-20 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 141,835 |
| 2015-08-20 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 275,022 | ||
| 2015-08-18 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $95.69 | $232K | 152,706 |
| 2015-08-18 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $95.69 | $232K | 152,706 |
| 2015-08-17 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +20,000 | $0.30 | $6K | 151,835 |
| 2015-08-17 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $92.24 | $1.8M | 131,835 |
| 2015-08-17 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −20,000 | 285,022 | ||
| 2015-08-17 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $94.21 | $229K | 155,132 |
| 2015-08-17 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $94.18 | $228K | 155,132 |
| 2015-08-10 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $31.64 | $174K | 39,570 |
| 2015-08-10 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $100.00 | $550K | 34,070 |
| 2015-08-10 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 296,380 | ||
| 2015-08-06 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 131,835 |
| 2015-08-06 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 305,022 | ||
| 2015-08-03 | Schenkein David P Chief Executive Officer | Exercise or conversion | +701 | $0.30 | $212 | 232,973 |
| 2015-08-03 | Schenkein David P Chief Executive Officer | Exercise or conversion | +7,299 | $31.64 | $231K | 240,272 |
| 2015-08-03 | Schenkein David P Chief Executive Officer | Sale | −8,000 | $110.60 | $885K | 232,272 |
| 2015-08-03 | Schenkein David P Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −701 | 878,619 | ||
| 2015-08-03 | Schenkein David P Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −7,299 | 871,320 | ||
| 2015-07-23 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +1,319 | $23.10 | $30K | 1,319 |
Page 87 of 93 · 1,853 trades